Immunity to Aspergillus fumigatus: the basis for immunotherapy and vaccination

References

• Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microb Rev 1999; 12: 310–350
   PubMed Web of Science ®Google Scholar
• Latgé JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001; 9: 382–389
   PubMed Web of Science ®Google Scholar
• Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–803
   PubMed Web of Science ®Google Scholar
• Marr KA, Patterson T, Denning D. Aspergillosis: Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin N Am 2002; 16: 875–894
   PubMed Web of Science ®Google Scholar
• Babbin BA, Greene JN, Vega R, et al. Pathologic manifestation of invasive pulmonary aspergillosis in cancer patients: the many faces of Aspergillus. Cancer Control 2000; 7: 566–571
   Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1–23
   PubMed Web of Science ®Google Scholar
• Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med 1999; 5: 1249–1255
   PubMed Web of Science ®Google Scholar
• Crameri R, Blaser K. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002; 19: 151–157
   PubMed Web of Science ®Google Scholar
• McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707–712
   PubMed Web of Science ®Google Scholar
• Allen MJ, Voelker DR, Mason RJ. Interactions of surfactant proteins A and D with Saccharomyces cerevisiea and Aspergillus fumigatus. Infect Immun 2001; 69: 2037–2044
   PubMed Web of Science ®Google Scholar
• McCormak, FX, Gibbons, R, Ward, SR, , et al. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278:36250–36256.
   Google Scholar
• Sato M, Sano H, Iwaki D, Kudo K, Konishi M. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion sre downregulated by lung collectin surfactant protein A. J Immunol 2003; 171: 417–425
   PubMed Web of Science ®Google Scholar
• Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688–693
   PubMed Web of Science ®Google Scholar
• Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003; 37: 733–737
   PubMed Web of Science ®Google Scholar
• Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184: 653–656
   PubMed Web of Science ®Google Scholar
• Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420: 182–186
   PubMed Web of Science ®Google Scholar
• Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1992; 69: 617–631
   Google Scholar
• Levitz SM, Diamond RD. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J Infect Dis 1985; 152: 33–42
   PubMed Web of Science ®Google Scholar
• Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004; 12: 44–49
   PubMed Web of Science ®Google Scholar
• Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signalling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320–39326
   PubMed Web of Science ®Google Scholar
• Wang JE, Warris A, Ellingsen EA, et al. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun 2001; 69: 2402–2406
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059–3069
   PubMed Web of Science ®Google Scholar
• Philippe B, Ibrahim-Granet O, Prevost MC, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003; 71: 3034–3042
   PubMed Web of Science ®Google Scholar
• Austyn JM. Dendritic cells. Curr Opinion Hematol 1998; 5: 3–15
   PubMedGoogle Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001; 106: 263–266
   PubMed Web of Science ®Google Scholar
• Shortman K, Heath WR. Immunity or tolerance? That is the question for dendritic cells. Nat Immunol 2001; 2: 988–989
   Google Scholar
• Shortman K, Liu YJ. Mouse and human dendritic cells subtypes. Nat Immunol 2002; 2: 151–161
   Web of Science ®Google Scholar
• Pollard AM, Lipscomb MF. Characterization of murine lung dendritic cells: Similarities to Langerhans cells and thymic dendritic cells. J Exp Med 1990; 172: 159–167
   PubMed Web of Science ®Google Scholar
• Holt PG. Antigen presentation in the lung. Am J Respir Crit Care Med 2000; 162: 151–156
   PubMed Web of Science ®Google Scholar
• Stumbles PA, Thomas JA, Pimm CL, et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998; 188: 2019–2031
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Pauwels RA, Fazekas de St. Groth B. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J Immunol 2000; 164: 2937–2946
   PubMedGoogle Scholar
• Holt PG, Stumbles PA, McWilliam AS. Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J Leuk Biol 1999; 66: 272–275
   PubMed Web of Science ®Google Scholar
• Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725–791
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Puccetti P. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol 2002; 10: 508–514
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362–1371
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Gaziano R, et al. Thymosin α 1 activates dendritic cells for antifungal Th 1 resistance through Toll-like receptor signaling. Blood 2004; 103: 4232–4239
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002; 4: 1281–1290
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358–4366
   PubMed Web of Science ®Google Scholar
• Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 654–662
   PubMed Web of Science ®Google Scholar
• Roilides E, Katsifa H, Walsh TJ. Pulmonary host defenses against Aspergillus fumigatus. Res Immunol 1998; 149: 454–465
   PubMedGoogle Scholar
• Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematological malignancies. Blood 2002; 100: 4521–4527
   PubMed Web of Science ®Google Scholar
• Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J Infect Dis 1997; 176: 1579–1583
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Fe' d'Ostiani C, et al. Cytokine and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178: 1750–1760
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Bacci A, et al. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000; 165: 381–388
   PubMed Web of Science ®Google Scholar
• Roilides E, Sein T, Roden M, Schaufele RL, Walsh TJ. Elevated serum concentrations of Interleukin-10 in non neutropenic patients with invasive aspergillosis. J Infect Dis 2001; 183: 518–520
   PubMed Web of Science ®Google Scholar
• Romani L. The T cell responses against fungal infections. Curr Opin Microbiol 1997; 9: 484–490
   Google Scholar
• Kurup VP, Mauze S, Choi H, Seymour BW, Coffman RL. Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines. Peptides 1996; 17: 183–190
   PubMed Web of Science ®Google Scholar
• Kurup VP, Hari V, Guo J, Seymour BW, Coffman RL. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 1992; 148: 3783–3788
   PubMed Web of Science ®Google Scholar
• Knutsen AP, Mueller KR, Levine AD, Choulan B, Hutcheson PS, Slavin RG. Asp f I CD4+ TH2-like T-cell lines in in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994; 94: 215–221
   PubMed Web of Science ®Google Scholar
• Crameri R, Faith A, Hemmann S, et al. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 1996; 184: 265–270
   PubMed Web of Science ®Google Scholar
• Mayer C, Appenzeller U, Seelbach H, et al. Humoral and cell-mediated autoimmune reaction to human acidic ribosomal P2 protein in individual sensitized to Aspergillus fumigatus P2 protein. J Exp Med 1999; 189: 1507–1099
   PubMed Web of Science ®Google Scholar
• Kurup VP, Choi HY, Murali PS, et al. Immune response to Aspergillus antigen in IL-4−/ −  mice and affect of eosinophil ablation. Allergy 1999; 54: 420–427
   Google Scholar
• Grunig G, Corry DB, Leach MV, et al. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997; 185: 1089–1099
   PubMed Web of Science ®Google Scholar
• Robertson MD, Seaton A, Milne LJ, Raeburn JA. Suppression of host defences by Aspergillus fumigatus. Thorax 1987; 42: 19–25
   PubMed Web of Science ®Google Scholar
• Pahl HL, Krausz B, Schulze-Osthoff K, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J Exp Med 1996; 183: 1829–1840
   PubMed Web of Science ®Google Scholar
• Tilden EB, Williamson WM. Unusual tuberculous lesion in a wallaby. J Am Vet Med Assoc 1957; 131: 526–527
   Google Scholar
• Tilden EB, Hatton EH, Freeman S, Williamson WM, Koenig VL. Preparation and properties of the endotoxins of Aspergillus fumigatus and Aspergillus flavus. Mycopathologia 1961; 14: 325–346
   Google Scholar
• Asakura S, Nakagawa S, Masui M. Immunological studies of aspergillosis in birds. Mycopathol Mycol Appl 1962; 18: 249–256
   Google Scholar
• Richard JL, Thurston JR, Cutlip RC, Pier AC. Vaccination studies of aspergillosis in turkeys: subcutaneous inoculation with several vaccine preparations followed by aerosol challenge exposure. Am J Vet Res 1982; 43: 488–492
   PubMed Web of Science ®Google Scholar
• Richard JL, Peden WM, Sacks JM. Effects of adjuvant-augmented germling vaccines in turkey poults challenged with Aspergillus fumigatus. Avian Dis 1991; 35: 93–99
   PubMed Web of Science ®Google Scholar
• Svirshchevskaya E, Frolova E, Alekseeva L, Kotzareva O, Kurup VP. Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f 1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice. Peptides 2000; 21: 1–8
   PubMed Web of Science ®Google Scholar
• Ito JI, Lyons JM. Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. J Infect Dis 2002; 186: 869–871
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Spreca A, et al. Protection of killer antidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect Immun 2002; 70: 2375–2382
   PubMed Web of Science ®Google Scholar
• Kisch AI, Echols RM, Maydew RP. Protective efficacy of antifungal immunization in opportunistic murine pulmonary aspergillosis. Clin Res 1979; 27: 83–88
   Google Scholar
• Einsele H. Antigen-specific T cells for the treatment of infections after transplantation. Hematol J 2003; 4: 10–17
   PubMedGoogle Scholar
• Bozza S, Perruccio K, Montagnoli C, et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 2003; 102: 3807–3814
   PubMed Web of Science ®Google Scholar
• Bacci A, Montagnoli C, Perruccio K, et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 2002; 168: 2904–2913
   PubMed Web of Science ®Google Scholar
• Bozza S, Montagnoli C, Gaziano R, et al. Dendritic cell-based vaccination against opportunistic fungi. Vaccine 2004; 22: 857–864
   PubMed Web of Science ®Google Scholar
• Ni H, Capodici J, Cannon G, et al. Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-a secretion and signaling through a nucleotide receptor. J Biochem Chem 2002; 277: 12689–12696
   Google Scholar
• Mencacci A, Perruccio K, Bacci A, et al. Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood 2001; 97: 1483–1490
   PubMed Web of Science ®Google Scholar
• Velardi A, Terenzi A, Cucciaioni S, et al. Imbalances within peripheral blood T-helper (CD4 + ) and T-suppressor (CD8 + ) cell population in the reconstitution phase after human bone marrow transplantation. Blood 1988; 71: 1196–1200
   Google Scholar
• Verfuerth SK, Peggs PV, Barnett L, O'Reilly RJ, Mackinnon S. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusion on T-cell repertoire. Blood 2000; 95: 3990–3995
   PubMed Web of Science ®Google Scholar
• Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation – Friend or foe?. Immunity 2001; 14: 357–368
   PubMed Web of Science ®Google Scholar
• Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 2002; 109: 1519–1526
   PubMed Web of Science ®Google Scholar
• Stevens DA. Vaccinate against aspergillosis! A call to arms of the immune system. Clin Infect Dis 2004; 38: 1131–1136
   PubMed Web of Science ®Google Scholar
• Sheppard, DC, Edwards, JE, Jr. Development of a vaccine for invasive aspergillosis. Clin Infect Dis 2004; 38:1137–1138.
   PubMed Web of Science ®Google Scholar